JPH2: Junctophilins contribute to the formation of junctional membrane complexes (JMCs) which link the plasma membrane with the endoplasmic or sarcoplasmic reticulum in excitable cells. Provides a structural foundation for functional cross-talk between the cell surface and intracellular calcium release channels. JPH2 is necessary for proper intracellular Ca(2+) signaling in cardiac myocytes via its involvement in ryanodine receptor-mediated calcium ion release. Contributes to the construction of skeletal muscle triad junctions. Defects in JPH2 are the cause of familial hypertrophic cardiomyopathy type 17 (CMH17). CMH17 is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. Belongs to the junctophilin family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Contractile; Membrane protein, integral; Endoplasmic reticulum
Chromosomal Location of Human Ortholog: 20q13.12
Cellular Component: junctional membrane complex; integral to membrane; plasma membrane; Z disc
Molecular Function: phosphatidylinositol-4,5-bisphosphate binding; protein binding; phosphatidylinositol-3,4,5-triphosphate binding; phosphatidylserine binding; calcium-release channel activity; phosphatidylinositol-5-phosphate binding; phosphatidylinositol 3-phosphate binding
Biological Process: calcium ion homeostasis; regulation of cardiac muscle development
Disease: Cardiomyopathy, Familial Hypertrophic, 17
Show more